Unicycive Therapeutics Price Chart
Unicycive Therapeutics Volume Chart
Unicycive Therapeutics Market Segments
Regular Trading Hours
-0.13(-1.60%)
| Open | $7.80 |
|---|---|
| Close | $7.68 |
| Low | $7.55 |
| Low Change | -0.25 (-3.21%) |
| High | $7.90 |
| High Change | +0.10 (+1.28%) |
| Range | $0.35 |
| Volume | 344.808K |
| Dollar Volume | $2.65M |
Premarket
+0.16(+2.09%)
| Open | $7.65 |
|---|---|
| Close | $7.81 |
| Low | $7.65 |
| Low Change | 0.00 (0.00%) |
| High | $7.81 |
| High Change | +0.16 (+2.09%) |
| Range | $0.16 |
| Volume | 23.852K |
| Dollar Volume | $186.28K |
After Hours Yesterday
-0.05(-0.65%)
| Open | $7.66 |
|---|---|
| Close | $7.61 |
| Low | $7.51 |
| Low Change | -0.15 (-1.96%) |
| High | $7.68 |
| High Change | +0.02 (+0.26%) |
| Range | $0.17 |
| Volume | 4.029K |
| Dollar Volume | $30.66K |
Regular Trading Hours Yesterday
+0.42(+5.83%)
| Open | $7.23 |
|---|---|
| Close | $7.65 |
| Low | $7.08 |
| Low Change | -0.15 (-2.07%) |
| High | $7.67 |
| High Change | +0.44 (+6.09%) |
| Range | $0.59 |
| Volume | 632.007K |
| Dollar Volume | $4.84M |
Premarket Yesterday
*No Trades in Segment
Unicycive Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $7.30 |
|---|---|
| 10 Day Moving Average (SMA10) | $7.32 |
| 20 Day Moving Average (SMA20) | $7.03 |
| 50 Day Moving Average (SMA50) | $6.87 |
| 100 Day Moving Average (SMA100) | $6.55 |
| 200 Day Moving Average (SMA200) | $5.60 |
Unicycive Therapeutics Statistics
| Average Volume (30 Days) | 519.93K |
|---|---|
| P/E Ratio (Current) | -6.83 |
| EPS (Current) | -$1.05 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$31.34M |
| Cash Ratio | 1.54 |
| Current Ratio | 2.59 |
| Quick Ratio | 2.59 |
| Debt to Equity | 0.00 |
| Enterprise Value | $151.76M |
| EV to EBITDA | -5.15 |
| EV to Sales | — |
| Price to Book | 5.99 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.54% |
| Return on Equity | -0.88% |
Unicycive Therapeutics Stock Splits
There has been 1 stock split for Unicycive Therapeutics (UNCY). The reverse stock split occured on June 20, 2025 and reduced the outstanding shares at a ratio of 10:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 20, 2025 | Reverse | 10:1 |
Unicycive Therapeutics Dividends
There have been no dividends for Unicycive Therapeutics (UNCY).